Research Article
Volume 4 Issue 9 - 2020
Evaluation of NT-PROBNP Levels in Egyptian Patients with Type 2 Diabet
Mona Sadek1, Hassan A Shora2*, Lamiaa Barakat3 and Naglaa El-liethy1
1Professor of Biochemistry, Faculty of Girls, Ain Shams University, Cairo, Egypt
2Senior Research Scientist, Head of Medicine and Diabetes Center, Port-Said University, Port-Said and Ismailia General Hospital, Egypt
3Professor and Chairman of Biochemistry Department, Faculty of Science, Port-Said University, Egypt
*Corresponding Author: Hassan A Shora, Senior Research Scientist, Head of Medicine and Diabetes Center, Port-Said University, Port-Said and Ismailia General Hospital, Egypt.
Received: July 16, 2020; Published: August 20, 2020




Abstract

Background: The N-terminal pro brain natriuretic peptide (Nt-proBNP) is known to be associated with cardiac stress. This study aimed to assess Nt-proBNP levels in type 2 diabetic patients without overt cardiac complications and to evaluate it in patients with microvascular complications.

Methods: We evaluated the Nt-proBNP levels in the study population which was grouped as: group one, control healthy subjects and group 2, type two diabetic patients with and without microvascular complications.

Results: Patients with type 2 diabetes were shown to have higher Nt-proBNP levels than control subjects and patients with microvascular complications of type 2 diabetes were shown to have higher Nt-proBNP values than patients without microvascular complications.

Conclusion: Our study findings of elevated Nt-proBNP levels in type 2 diabetic patients without overt cardiac disease, suggesting that type 2 diabetes having some degree of cardiac strain, even if non clinically diagnosed and may be beneficial as screening method to guide selection of type 2 diabetic patients who need dedicated cardiac investigations.

Keywords: Type 2 Diabetes Mellitus; N-Terminal Brain Natriuretic Peptide; Microangiopathy

References

  1. Gaurav S., et al. “Diabetic cardiomyopathy: prevalence, determinants and potential treatments”. Therapeutic Advances in Endocrinology and Metabolism (2019): 10.
  2. Cho NH., et al. “IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045”. Diabetes Research and Clinical Practice 138 (2018): 271-281.
  3. Hamano K., et al. “N-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes”. Vascular Health and Risk Management 10 (2014): 585-589.
  4. Forbes J and Cooper M. “Mechanisms of Diabetic Complications”. Physiological Reviews 93 (2013): 137-188.
  5. Gruden G., et al. “NH2-terminal probrain natriuretic peptide is associated with diabetes complications in the EURODIAB Prospective Complications Study: the role of tumor necrosis factor-α”. Diabetes Care9 (2012): 1931-1936.
  6. Bruno G., et al. “NT-proBNP Linking Low Moderately Impaired Renal Function and Cardiovascular Mortality in Diabetic Patients: The Population-Based Casale Monferrato Study”. PLoS ONE 12 (2014): e114855.
  7. Beer S., et al. “Increased plasma levels of N-terminal brain natriuretic peptide (NT-proBNP) in type 2 diabetic patients with vascular complications”. Diabetes and amp Metabolism6 (2005).
  8. Panagiotakos D., et al. “The Relationship between Dietary Habits, Blood Glucose and Insulin Levels among People without Cardiovascular Disease and Type 2 Diabetes; The ATTICA Study”. The Review of Diabetic Studies 4 (2005): 208-215.
  9. Bernard A., et al. “Determination of beta 2-microglobulin in human urine and serum by latex immunoassay”. Clinical Chemistry 27 (1981): 832-837.
  10. Peake M and Whiting M. “Measurement of serum creatinine-current status and future goals”. The Clinical Biochemist Reviews 4 (2006): 173-184.
  11. Lambers Heerspink HJ., et al. “Gansevoort RT PREVEND Study Group. Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality”. American Journal of Epidemiology 168 (2008): 897-905.
  12. Pal S., et al. “The Effect of a Low Glycaemic Index Breakfast on Blood Glucose, Insulin, Lipid Profiles, Blood Pressure, Body Weight, Body Composition and Satiety in Obese and Overweight Individuals: A Pilot Study”. Journal of the American College of Nutrition3 (2008): 387-393.
  13. Hempe JM., et al. “Estimated average glucose and self-monitored mean blood glucose are discordant estimates of glycemic control”. Diabetes Care 33 (2010): 1449-1451.
  14. Salgado AL., et al. “Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals”. Arquivos de Gastroenterologia 2 (2010): 165-169.
  15. Stanley FLo., et al. “Laboratory Performance in Albumin and Total Protein Measurement Using a Commutable Specimen: Results of a College of American Pathologists Study”. Archives of Pathology and Laboratory Medicine7 (2013): 912-920.
  16. Drion I., et al. “Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques”. BMC Nephrology 13 (2012): 133.
  17. Nagai T., et al. “Brain natriuretic polypeptide in type 2 NIDDM patients with albuminuria”. Journal of Medicinal Chemistry 32 (2001): 169-180.
  18. Barakat L., et al. “Correlation of Iron Binding Stores with Cardio metabolic risks in Obesity and Type 2 Diabetes Mellitus in Egyptian population”. Acta Velit 1 (2017).
  19. Regitz-Zagrosek V., et al. “Gender differences in the metabolic syndrome and their role for cardiovascular disease”. Clinical Research in Cardiology 3 (2006): 136-147.
  20. Regitz-Zagrosek V., et al. “Gender Aspects of the Role of the Metabolic Syndrome as a Risk Factor for Cardiovascular Disease”. Gender Medicine 4 (2007): S162-S177.
  21. Szalat A and Raz I. “Gender-specific care of diabetes mellitus: particular considerations in the management of diabetic women”. Diabetes, Obesity and Metabolism 12 (2008): 1135-1156.
  22. Gale EA and Gillespie KM. “Diabetes and gender”. Diabetologia 1 (2001): 3-15.
  23. Wild S., et al. “Global prevalence of diabetes: estimates for the year 2000 and projections for 2030”. Diabetes Care 5 (2004): 1047-1053.
  24. Adams KF., et al. “Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old”. The New England Journal of Medicine 355 (2006): 763-778.
  25. Flegal KM., et al. “Cause-specific excess deaths associated with underweight, overweight, and obesity”. The Journal of the American Medical Association 298 (2007): 2028-2037.
  26. Azab A., et al. “Correlation of serum resist in level with insulin resistance and severity of retinopathy in type 2 diabetes mellitus”. Journal of Saudi Chemical Society 20 (2016): 272-277.
  27. Abdel-Aziz T., et al. “Correlation of Triglycerides to High Density Lipoprotein Cholesterol Ratio with Insulin Resistance in Egyptian Population”. Indian Journal Of Applied Research8 (2013).
  28. Guh DP., et al. “The incidence of comorbidities related to obesity and overweight: a systematic review and meta-analysis”. BMC Public Health 9 (2009): 88-107.
  29. Rudra CB., et al. “Weight Characteristics and Height in Relation to Risk of Gestational Diabetes Mellitus”. American Journal of Epidemiology 165 (2007): 302-308.
  30. Astrup A and Finer N. “Redefining type 2 diabetes: ‘Diabesity’ or ‘obesity dependent diabetes mellitus’?” Obesity Reviews 1 (2000): 57-59.
  31. Hu FB., et al. “Diet, lifestyle, and the risk of type 2 diabetes mellitus in women”. Obstetrical and Gynecological Survey 57 (2002): 162-164.
  32. Richard N. “Obesity-Related Hypertension”. The Ochsner Journal 3 (2009): 133-136.
  33. Landsberg L and Molitch M. “Diabetes and hypertension: pathogenesis, prevention and treatment”. Clinical and Experimental Hypertension 26 (2004): 621-628.
  34. Abdel-Aziz T., et al. “Correlation Of Serum C-Reactive Protein with the Features of Metabolic Syndrome and Associated Microangiopathy in Egyptian Population”. Indian Journal Of Applied Research7 (2013).
  35. Barakat L., et al. “Pro-inflammatory Cytokines Levels in Obese and Diabetic Egyptians and its Correlation with Cardiometabolic Syndrome”. Journal of Basic Sciences and Applied Research 2 (2017): 77-81.
  36. Bernard MY and Cheung Chao Li. “Diabetes and Hypertension: Is There a Common Metabolic Pathway? Current Atherosclerosis Reports2 (2012): 160-166.
  37. Amartey K Nsiah and FO Mensah. “Plasma Levels of Uric Acid, Urea and Creatinine in Diabetics Who Visit the Clinical Analysis Laboratory (CAn-Lab) at Kwame Nkrumah University of Science and Technology, Kumasi, Ghana”. Journal of Clinical and Diagnostic Research 2 (2015): 05-09.
  38. Momin AR., et al. “Albumin/Creatinine Ratio, As Predictor of Microalbuminuria, a Risk Factor For Nephropathy In Type 2 Diabetes Mellitus Patients”. International Journal of Health Sciences and Research2 (2011): 256.
  39. Rao G. “Insulin resistance syndrome”. American Family Physician (2001): 63-66.
  40. Barakat L., et al. “Cut Off Value of Serum Adiponectin Levels in Egyptian Patients with Metabolic Syndrome”. Asian Journal Of Research In Medical And Pharmaceutical Sciences 4 (2017): 1-8.
  41. Jarolim P., et al. “Serial Measurement of Natriuretic Peptides and Cardiovascular Outcomes in Patients With Type 2 Diabetes in the EXAMINE Trial”. Diabetes Care 7 (21018): 1510-1515.
  42. Hijazi Z., et al. “Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy”. Circulation 125 (2012): 1605-1616.
  43. Tarnow L., et al. “Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes”. Diabetologia 49 (2006): 2256-2262.
  44. Huang F., et al. “The influence of body composition on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with acute coronary syndrome: a cohort study”. Cardiovascular Diabetology 15 (2016): 58.
Citation: Hassan A Shora., et al. “Evaluation of NT-PROBNP Levels in Egyptian Patients with Type 2 Diabetes". EC Diabetes and Metabolic Research 4.9 (2020): 20-27.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.